| Active Pharmaceutical Ingredients Manufacturing | Production of antibacterial and anti-infective APIs and intermediates | Long-standing expertise in key APIs; integrated manufacturing reducing dependence on suppliers; export market presence | Pharmaceutical companies globally (B2B), including multinational firms | Backward integrated intermediates like Sulphamethoxide and Diethyl Oxalate increasing value addition | 113 | 100 | Sales of APIs and intermediates to pharmaceutical companies, loan license manufacturing contracts | Direct sales based on contracts and orders; typically bulk supply agreements | Capacity expansion, backward integration, demand for key antibacterial APIs worldwide, regulatory compliance | Sulphamethoxazole (SMX), Trimetroprim (TMP), Pyrazyamide |
